Entourage Health to Hold First Quarter 2024 Financial Results Call on May 28

Financial filings are expected after the market closes on May 27, and a management conference call will follow the next day

TORONTO, May 14, 2024 (GLOBE NEWSWIRE) — Entourage Health Corp. (TSX-V:ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products announced today it will file its first quarter 2024 financial statements and management’s discussion and analysis after market close on Monday, May 27, 2024. Entourage will host a conference call the following day on Tuesday, May 28, 2024, at 10:00 am Eastern Time to review the results and provide an operational update. 

Conference Call Details:

CEO and Executive Chair George Scorsis and CFO Vaani Maharaj will host the conference call. Following the opening remarks, management will be available for questions. 

Date:
Tuesday, May 28, 2024

Time:
10:00 am Eastern Time

Dial-in Number:
Canada/USA: 1-844-763-8274
International Toll: 1-647-484-8814
Participants, please dial in and ask to join the Entourage call

Replay Dial-in:
Canada/USA: 1-855-669-9658
Replay Access Code: 0899
Available after 12:00 p.m. Eastern Time until June 28, 2024

About Entourage Health Corp. 

Entourage Health Corp. is the publicly traded parent Company of Entourage Brands Corp., a licence holder producing and distributing cannabis products for the medical and adult-use markets. The Company owns and operates a fully licensed 26,000 sq. ft. Aylmer, ON processing facility. With its Starseed Medicinal medical-centric brand, Entourage has expanded its multi-channelled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with employers and union groups, complements Entourage’s direct sales to medical patients. Entourage’s elite adult-use product portfolio includes Color Cannabis, Saturday Cannabis – and now Dime Bag and Syndicate – sold across eight provincial distribution agencies. Exclusive Canadian producer and distributor of award-winning U.S.-based wellness brand Mary’s Medicinals, sold in both medical and adult-use channels in addition, Entourage also entered into an exclusive agreement with Irwin Naturals, nutraceutical and herbal supplement formulator of popular branded wellness products sold across North America. 

Follow Entourage and its brands on LinkedIn 
Instagram: Color Cannabis, Saturday Cannabis, Starseed, Syndicate, Dime Bag

For Investor & Media Enquiries:
Catherine Flaman
Senior Director, Communications & Corporate Affairs
416-910-0279
Catherine.flaman@entouragecorp.com

Forward Looking Information This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation which are based upon Entourage’s current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward looking information can be identified using forward-looking terminology such as “expect,” “likely,” “may,” “will,” “should,” “intend,” “anticipate,” “potential,” “proposed,” “estimate” and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions “may,” “would” or “will” happen, or by discussions of strategy.

The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions, and views of future events which management believes to be reasonable in the circumstances. Forward looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance, or other statements that are not statements of fact. Forward looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of Entourage to implement its business strategies; competition; crop failure; and other risks.

Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, Entourage does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for Entourage to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in Entourage’s disclosure documents filed with the applicable Canadian securities regulatory authorities and available on SEDAR+ at www.sedarplus.ca. The risk factors and other factors noted in the disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.